UNSPSC 51284007: Etamocycline

This classification denotes a tetracycline antibiotic with the molecular formula C50H60N6O16, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 96D1L38S9Q chemically known as n,n,-(ethylenebis((methylimino)methylene))bis-(4'-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide) but generally known as etamocycline, which bears US NIH Compound Identifier 5464330.

UNSPSC 51284007 Etamocycline, a Commodity code, does not align with recent state and local procurement activity. The code nominally identifies a specific tetracycline antibiotic, but the two recent opportunities posted under it involve pharmaceutical warehouse supply of unrelated products—Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets through a cooperative purchasing vehicle, and Naloxone with drug deactivation systems through a county competitive bid. Neither procurement is buying etamocycline or related products.

State and local agencies have posted limited recent activity under this code. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for $2,999,999.11 over the life of the contract (12-month initial term with two renewal options), and Seminole County, Florida released an IFB for Naloxone and Safe Drug Deactivation Systems with a July 26, 2023 response deadline (though this appears to be a historical posting misdated in the source). The mismatch between the code's nominal scope and the actual products being solicited suggests that etamocycline may be misclassified in recent submissions or that this code sees minimal relevant state and local procurement activity.